MAPT and Cognitive impairment: However, it is not clear whether p-tau, VILIP-1, and YKL-40 provide independent or complementary information about AD and whether combinations of p-tau, VILIP-1, and YKL-40 increase the diagnostic accuracy for AD and mild cognitive impairment (MCI).